Lupin touched an intraday high of Rs 466 and an intraday low of Rs 454.90. At 15:14 hrs the share was quoting at Rs 454.90, down Rs 8.65, or 1.87%.
The company has launched Fortamet Generic at risk in the US, reports CNBC-TV18.
Fortamet is a USD 70 million diabetes drug. Lupin is currently under litigation with Shionogi & Watson.
It was trading with volumes of 60,879 shares. In the previous trading session, the share closed down 0.95% or Rs 4.45 at Rs 463.55.
| Share Price Movement During The Last 12 Months | ||||
| Period | Price | Latest Price | Gain/Loss (Rs.) | % Gain/Loss |
| 3-Days | 456.55 | 454.90 | -1.65 | -0.36 |
| 5-Days | 469.25 | 454.90 | -14.35 | -3.06 |
| 7-Days | 469.25 | 454.90 | -14.35 | -3.06 |
| 15-Days | 468.90 | 454.90 | -14.00 | -2.99 |
| 1-Month | 465.00 | 454.90 | -10.10 | -2.17 |
| 3-Month | 458.65 | 454.90 | -3.75 | -0.82 |
| 6-Month | 413.60 | 454.90 | 41.30 | 9.99 |
| 9-Month | 463.00 | 454.90 | -8.10 | -1.75 |
| 1-Year | 422.65 | 454.90 | 32.25 | 7.63 |
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
